Happy New Year! The fact that this week’s portfolio moves included a little stop loss selling and some nibbles in asset management, insurance and music royalties probably tells you all you need to know about how cautious I feel to start this year… though, as always, I try not to have my personal sentiment drive […]
Articles
This update was posted on November 24, we’re re-sharing it here because of a huge number of new reader questions. It has NOT been updated or revised since we last posted an update on 11/24/2020, when Ray Blanco reporposed the ad to use the new invented target date of January 20 to replace September 22. […]
This article was originally published on December 1, 2020, but we’re seeing new versions with different headlines and that “March 2021” deadline, so we’re re-publishing our comments below. What follows has not been updated or revised in the past month. Lou Basenese is pitching Elon Musk’s next big idea in ads for his Trend Trader […]
The intro to this ad came in an email promo from Christian DeHaemer, who writes other newsletters for Angel publishing… here’s the key part, about his communication from Jeff Siegel: “But back to Jeff… We were on a Zoom call yesterday and he was telling me about this solar company that is using a spray […]
I’ve written about a bunch of “pre-IPO” investments in the past, but Ian Wyatt has probably been more relentless than anyone else in promoting this idea of “buying in before it’s public” … particularly when it comes to the hot “brand names” that excite investors. Wyatt’s latest pitch is for a “webinar” that will air […]
This article was originally published on April 23, 2020, when we first saw the ads from Paul Mampilly — most recently this has been more aggressively pitched with the idea of the “12 million mile battery,” so we’re re-posting our solution for you. The ad has not changed and is still dated April 2020, and […]
Shall we stop for a moment to sing an early “Happy Birthday” for Warren Buffett? He will turn 90 on Sunday. And maybe another surge in Berkshire’s share price will get his fortune up to $90 billion before too long, fingers crossed on that (OK, probably not, he’s giving away his money so quickly that […]
This week brought yet another push-pull to the markets as investors attempt to figure out whether Lucy is going to pull the football away from Charlie Brown again in the China trade talks, but the narrative that struck me as most interesting on the week was the line that was drawn in the economy by […]
Today I’ve got a few portfolio moves to share with you that go against the Wall Street mantra (“sell your losers, let your winners run”)… last night I sold my position in Kweichow Moutai in China — this is a fantastic company, mostly because they have insanely high profit margins on their signature Moutai liquor… […]
The first version of this article ran way back on March 30, 2016, so it might look familiar to a lot of you — but a few folks asked about it today, and it looks like the ad is running again, still without much change to the spiel, so I’m re-publishing this teaser solution. I’ve […]
Lots to discuss this week, mostly because several Real Money Portfolio companies reported earnings… and because I added money to two positions this week, and brought a new company into the portfolio. Enjoy! Shopify (SHOP) had reasonable earnings when they came out, but “reasonable” isn’t enough for a high-growth momentum stock that’s trading at almost […]
What do I think? That’s what a lot of readers are asking during these volatile days… and there is, of course, no easy answer. My thoughts are all over the place, so today’s Friday File musings are going to run the gamut. Tesla (TSLA) is a good example of how the market is treating investors […]
The talk of trade war with China is bringing the idea of Chinese mineral dominance back to the pages of investment teaser ads… we’ve seen several in the last week or two that focus on rare earths, where China remains dominant and might have some extra negotiating leverage in trade disputes, and this latest pitch […]
Jason Stutman’s “upgrade” newsletter, The Cutting Edge ($1,499/yr), is out with a teaser campaign that promises you the chance at riches from “Charged Ore” … and, in fact, an actual sample of that ore itself as part of your subscription. So what is “Charged Ore,” and what’s this little Nebraska mine that Stutman thinks will […]
Christian DeHaemer is pushing an ad recently that focuses on a Tesla alternative, and his latest free email touted the appeal of buying it after this latest market shakeup. So what’s the story? The ad is for his Bubble and Bust Report, which sounds like an entry-level monthly stock picking newsletter ($49/year, compared to his […]
I like David Einhorn, though I don’t know him (at least as far as I know, he was a year or two ahead of me in school, at the same University and in the same major, so perhaps we shared a beer or a study session at some point), but someone has to remind him […]
I know a lot of my readers follow Paul Mampilly pretty ardently, partly because of the fact that his publisher, Banyan Hill, is one of the more aggressive promoters in newsletterdom these days, and partly because he made some very strong picks with his first, heavily promoted service — particularly the teased pick of STMicroelectronics […]
Several readers have asked me this week what “Dividend Superstations” are… so that’s the target for the Thinkolator today. The ad comes from Brett Owens for his Contrarian Income Report, which is usually sold as a service that looks for a “secure 8% ‘no withdrawal’ return” for retirement — an admirable goal, and not terribly […]
The latest Keith Kohl ad caught my eye, since I’ve been interested in cobalt for a while now and figured that “blue gold” probably means he’s teasing that metal … so what’s the story, is it cobalt he’s talking about, and what’s the cobalt-related investment that he thinks will make us 1,000%-type gains? Well, he […]
It’s been a long time since I looked at an Australian teaser pick, so this new pitch for the Motley Fool Australia’s Share Advisor (A$199/yr) caught my eye. The Motley Fool, well known as a US newsletter publisher and investment community/website in the 25 years or so since the Gardner brothers started their AOL chat […]
A few readers have asked about this recent Motley Fool Stock Advisor promotion, so I thought I’d take a quick look-see for you today… apropo for “Apple Week,” it was all about Apple’s next “secret project” and “3 stocks to buy before Apple unveils its next must-have product.” So what is it? Well, I’ll spare […]
Lots of questions rolling in about this one — it’s a pitch for Sean Brodrick’s Oxford Resource Explorer, which these days is offered at $79 a year (or $49 for email-only)… though the letter is actually signed by David Fessler, one of their analysts who has generally been touted as an energy and resource expert […]
Today we’ve got a pitch from Nicholas Vardy’s Alpha Investor Letter, and it is blissfully not about the election at all. Let’s all just breathe a sign of relief, “ahhhhhhhhh.” Soon, one hopes, every day will be like this moment. Here’s what caught my eye about this “personal invitation” from Nicholas Vardy: “Discover the Profit […]
Getting a bit of your usual Friday File commentary out on the early side this week, since I made a personal purchase that I thought might interest my favorite Irregulars. And by purchase I mean “dumb speculation,” really — I picked up some shares of a junior miner that’s way too small to take seriously, […]
This ad has been simply unavoidable over the last couple days, and we covered the “headline” stock that Moors says has its tentacles in everay aspect of solar energy in yesterday’s piece… but the teaser pitch from Energy Advantage says there are two other stocks to be bought as well. What are they? Well, time […]
This article first ran on September 15, 2014, when almost exactly the same ad was sent around teasing Cabot’s September “Stock of the Month” … … now, in February, they’re just calling it the “Top Stock of the Month.” Not much in the ad has changed, and the stock is about 10% cheaper now than […]
Michael Robinson is out with a pitch for a company that he thinks will profit as “Tesla’s silent partner” in “Operation Bluestar” — and, naturally, Gumshoe readers are just dying to know who it is. Without, of course, ponying up for a subscription to his Nova-X Report newsletter — though that is, apparently, Robinson’s “entry […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Zeke Ashton has presented at several of these conferences in the past and usually has interesting ideas. He runs Centaur Capital Partners, mostly a hedge fund guy but also […]
I’ve gotten quite a few questions about the latest pitch from Ian Wyatt for his $100K Portfolio newsletter — this is his letter that tracks the trades of a $100,000 real money portfolio of his own money, started up a couple years ago when every newsletter publisher was trying out a “real money” letter. I […]
Ian Wyatt is out with a new teaser promo for his $100K Portfolio service, and it’s all about a young company that’s growing rapidly and changing America in a substantial way … with a free new “highway” across the country. He pitches this secret stock using the same kind of language that several other growth-focused […]
This is the Friday File, our missive to our favorite members (yes, we mean “the people who pay us”), so we can be a bit more up front with you and not make you sit through the entire spiel (though we’ll give you a full spiel-look as well) … David Gardner is now aggressively touting […]
The Value Investing Congress is always fun, and I’ll be trying to learn plenty that I can share with you in the weeks ahead (and, hopefully, become a better investor myself in the process), but this year I decided to spend a bit more time in New York and take in the pre-Congress seminar as […]
I wrote about Hilary Kramer and her new(ish) GameChangers newsletter for the first time just a couple weeks ago — so it’s certainly too early to judge whether her teaser stocks tend to perform as she predicts (that pick, Metalico, is down about 10% from when I wrote about it … but I don’t hold […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I am a paid up..expensive user.. I would like to say it is great so others can face the same drain of capital. Same o...
I signed up for the Zacks home study (including Research Wizard) course & paid a small fee for this. In using this ...
I'm considering a lifetime membership with Zacks, so if theres any feedback from anyone on Zacks it would be much apprec...
Whether DOMO is Mampilly’s teased company or not, I found three recent articles (March & April 2019) highly recommendi...
I subscribed to Zacks service and for my $350 for a year I got the lower end portfolio info, under 10, home run, etc.. ...
Here's a current Zacks report that will provide more clarity: http://s1.q4cdn.com/460208960/files/News/2017/Dec-20-2017...
Does anyone have any feedback on using Zacks Research Wizard software as a lifetime member? If so have long have you use...
bunion, He could do that but then he could also be sued. You may not reproduce, retransmit, disseminate, sell, publi...
I've seen nothing but mediocrity out of Zacks, so I don't understand at all where you are coming from. GT recommended A...
If you like spending your time watching videos and listening to Andy upsell all his financial buddies, buy his outragiou...
Alteryx (AYX) has been on Zacks specialty service radar as recently as Q4 2018....
Travis, can you research Zacks Weekly Black Box and advise...
Dear Travis and/or Irregulars, Would any of you know or be willing to share Zack's "Top 10 Stocks for 2019"? No matter ...
I second all that you said. PM is so much more comprehensive and I always learn something every time he sends his podcas...
Left identified INGN as his next short target, May 24 when it was at 170. It momentarily dropped to 157 but then went o...
I think new investors can learn a lot from learning how Zack's (and similar ratings firms) generate their ratings, and a...
More of a general question but how accurate do you find the zacks rankings when looking at whether to buy or sell stocks...
$DMCAF STROKE DiaMedica Therapeutics Like $ARTH I believe $DMCAF is a derisked situation that I believe there coul...
I have an account with interactive brokers through Zacks Trade Pro. Tried to buy CSE: XMG, MGX Minerals. A warning indi...
Zacks has OLED with an underperform rating, as does Columbine Capital Services, ValuEngine and Institutional Shareholder...
Okay, so this was back in January. I bought a little TTD back in March and it's up 71% since then, much more than anyth...
Whoo boy,ya gotta have some big brass ones to start monkeying around with junk bonds, or even anything BBB rated these d...
$APTO 5/24/18 FROM https://www.thelincolnianonline.com/2018/05/24/aptose-biosciences-apto-sees-large-volume-increase.ht...
Sounds like you feel aboutBlanco the way I feel about Zack’s – whatever they recommend, do the opposite. Luckily on...
Recently read Zack's book on stock screeners and was wondering if there are any fundamental indicators that you consiste...
Zacks stock services is always teasing their highly rated stock pics - and for exorbitant fees. Have you investigated t...
Travis regarding your comment above on the NVDA analyst average 'buy' target of $236. Below is a chart from Zacks Commen...
I subscribed to the Research Wizard a couple years ago. I use their recommendations from the different strategies. I use...
Seems as if The Chemours Company (CC) has attracted some attention lately. Apart for Louis Navalier (who will pitch anyt...
The folks at ValuEngine must be the most astute analysts in the business based upon this "upgrade"? Aptose Biosciences ...
Zack's rank 4B (sell)...
Thanks for the feedback — Zacks is mostly a quantitative system, similar to Navellier or Cabot, so they pretty much ne...
Zack's has it as a strong sell!...
did you see DQ was upgraded to buv by zacks analysts last night and on 24/01 Navellier associates purchased 29,400 share...
$SNDX long In case people were wondering about a nice bit of upward movement in SNDX today, there was a Zacks note fr...
$MEIP Long - I have no options on phase 3 drug candidate but I share what I found of interest recently: minimal inside o...
$MICT np - Micronet Enertec Technologies Signs Definitive Agreement to Sell its Defense and Aerospace Subsidiary, Ene...
$DXC - Wild ride https://finviz.com/quote.ashx?t=dxc #TIDAL ;-) Jan-02-18 07:38AM Zacks.com highlights: Estee Lauder...
$CWBR xxowxx - If any one knows of an analyst or five, please have them write a report, a blog or two and rub elbows wit...
$zacks Certainly looks like KSS has caught on in Zacksland. They traffic primarily in earnings derived metrics, and b...
It looks Like Zacks analysts are Dr. KSS fans!...
$VRNA Zacks: Brokerages Set $26.75 Target Price for Verona Pharma PLC American Depositary Share (VRNA) Dec 5, 2017 Cur...
I just viewed Chucks 45 min videos showing deep ITM options and his strategy of locking in a 30% profit with an ATM put ...
Did you ever take the plunge with Zack's Research Wizard? How is it doing?...
$ONOV $Zacktrades trade problem update: I received an email from Zack's apologizing for the confusion. As expected, li...
$ONOV Clearly, if Zacks cannot make limit orders of OTC stocks, they are in my rear view mirror. They indicated quite c...
If it is the market maker then that should apply to all brokers methinks. I would leave Zacks over such a practice mysel...
$ONOV small position Has anyone had any problems trading this stock? I have a small amount in an account at Zacks and t...
Zacks throws out a huge load of trades, but isn't very good at mathematics after that....
My experience with Oxford has not been positive. Trying to get $ back. Better off with Zacks and doing some dd....
Thank you Travis - much appreciated. I wonder why Zacks won't find CWBR....
This is pretty great material. Getting late. Defiantly have to do more research on EV's and get some positions in this m...
$MRTX np - Zacks has a 3, Hold recommendation. Tipranks has average price target of $11.67. https://www.tipranks.com/...
$RGLS Zacks upgrades Regulus to BUY this morning. The firm's current PT= $1.25 https://www.themarketsdaily.com/201...
Zack's #2 buy, Nutanix Inc. (NTNX)(Delayed Data from NSDQ) $21.56 USD September 15,2017 4:00 PM -0.05 (-0.23%) Look at...
I am a fairly new subscriber to Stock Gumshoe, really am impressed with the knowledge of so many investors here. My que...
Read all you can free on the web virtual magazine's. Good one's are Nasdaq, Motley Fool, Zack's, Seeking Alpha, The Str...
$PTGX "Brokerages Set $29.67 Price Target for Protagonist Therapeutics, Inc. (PTGX)" Monday, August 28th, 2017 ...
CBI is now down around the $10 mark. Zacks have marked it as the Bear of the Day. The long term tend is down down dow...
Automated scam. The fact they hide their $499 annual price and offer free deal and more deal. Just makes it non-trust wo...
I'm enjoying success with Zacks Under $10 Portfolio....
All of the investing world ignores Zack's computer-generated articles, and I believe we should do the same....
$RXDX RXDX listed as 1 of 4 "Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings".... I've had a partial position sin...
I recently "sat" through one of the Fool's long, drawn-out come-ons ... three years for $159 for their incredible advice...
Glad I stopped by, I too keep receiving emails so I sat thru the long video and it was just a another to good to be true...
$ARTH Price targets from different firms from that article are: Roth Captial: $3.00 Zacks Investment Research: $0...
The only kernel you will find in any of these email based, internet pitches is at the end of the day you are wasting you...
Zacks is usually late; I ignore them....
ARTH long old news Zacks Investment Research, Inc. upgrades ARCH THERAPEUTICS COM USD0.001 from HOLD to BUY...
Hi, Bill just a little bit of my style of investing. I never mess with options. I study stocks at as low as $.89 to $50...
Zacks had Amazon as a strong sell a month ago. Now it's 50 points higher....
Shop is a zacks strong sell....
$GNMX: SAGA Misses Primary Endpoint But Data Warrants Optimism Zacks Small Cap Research March 28, 2017 http://s...
Zacks is a contrarian indicator...
Long $RGLS The Zacks Investment Research Lowers Regulus Therapeutics Inc ($RGLS) to Sell and $RGLS up +0.20 (16.00%)...
Hi Sam: Still pretty hard for me to enthuse about $CBAY when the market offers an absolute embarrassment of scientifi...
Chip actually has it right. $AMAG (np) pre-announced their earnings today, lowering their guidance. It was below t...
That is just Zacks estimated earnings revision for $AMAG. Very misleading postings Chip12; AMAG has not revised its ear...
BTW - Zack's Research just put #PTN on "hold". I think this is a good sign to add to my position. jokin...
MarketBeatCom @RatingsNetwork Karyopharm Therapeutics downgraded by Zacks Investment Research to hold. $KPTI np ...
On May 12,2016 STM was $5.34, Reached a High of $9.45. That's a profit of $4.10 per share in 6 months. I let the results...
November 7, 2016 Chart: Polls for marijuana measures tight heading into Election Day http://mjbizdaily.com/wp-conten...
You'd be hard-pressed to find a broker who would make a portfolio of that quality for that price, is what I intended to ...
Reuters are not an investment banking or brokerage firm and don't do analysis. They are a news service and have, like y...
Thanks HN. What are your few recommendations that I should buy. There are so many out there that I don't know what to do...
Art, if you got in around $3.50 and it is $5.80 as I write, your golden. It will continue to run up to PUDFA on 14th. M...
I'm pretty sure this is a computer-written site. TheStreet.com does a lot of this, and so does Zack's. As Anamotph said,...
Welcome PMB. Regarding $SCYX share price, I am sure you know that bio stocks are extremely volatile, especially small ca...
The latest re: $STEM StemCells Inc. (NASDAQ:STEM) Receives Consensus Recommendation of “Buy” from Brokerages P...
I do my own homework turning $750 into $400k since 1986. Sure you lose some but it was my own fault leaving the guidelin...
Also, for those who are skeptical about the TRXC stock price, don't forget that: "Brokerage Recommendations: Accor...
I often check finance.google.com to check for news on stocks and invariably find a bunch of me-too type 'news' and 'rese...
ZACKS FYI...my ire is up about ZACK's because I strongly suspect they are trawling this website and pirating picks, whic...
$PVG $SSRI...ZACKS...another stupid thing that shows how superficial Zacks analysis is. They make a headline on SILVER, ...
ZACKS: what a joke. They publish some one-liner recruitment tags today pumping silver as an investment, and throw out ...
The analysts make me laugh. One sneezes and they all get a mild fever. They are all liking PVG now. Zacks suggested high...
#ZACKS - 4 Event Risks for the Rally a message from Reity and Kevin ($1 offer, Please understand that beyond $1 there i...
I am no longer a paying member of member of zacks. This is merely information that I am passing on to increase your aw...
Zacks rating on TRXC 3-Hold 3 Value: F | Growth: F | Momentum: F | VGM: F Be careful with TRXC. Like others ...